Clinical Trial Update: Long-Circulating Liposomal Prednisolone Versus Pulse Intramuscular Methylprednisolone in Patients With Active Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial comparing long-circulating liposomal prednisolone to pulse intramuscular methylprednisolone in patients with active rheumatoid arthri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Liposomal prednisolone (long-circulating formulation) (prednisolone liposome formulation)
• METHYLPREDNISOLONE (methylprednisolone)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED